Table 1 Basic characteristics of ACS patients with T2DM, without T2DM and overall.
Variables | Overall (n = 425) | Non-T2DM (n = 338) | T2DM (n = 87) | P value |
|---|---|---|---|---|
TBA, µmol/L, median (IQR) | 3.1 (1.9–5.1) | 3.0 (1.9–5.0) | 3.6 (1.9–5.4) | 0.015 |
Age, mean (SD) | 60.5 (10.5) | 59.6 (10.4) | 63.8 (9.9) | < 0.001 |
Male sex, n, % | 336, 79.1% | 273, 80.8% | 63, 72.4% | 0.088 |
BMI, kg/m2, mean (SD) | 25.0 (3.3) | 25.1 (3.3) | 24.9 (3.2) | 0.712 |
Past MI, n, % | 69, 16.2% | 58, 17.2% | 11, 12.6% | 0.308 |
Past PCI or CABG, % | 83, 19.5% | 66, 19.5% | 17, 19.5% | 0.998 |
Smoking, n, % | 242, 56.9% | 203, 60.1% | 39, 44.8% | 0.011 |
Family history, n, % | 170, 40.0% | 136, 40.2% | 34, 39.1% | 0.844 |
Hypertension, n, % | 224, 52.7% | 173, 51.2% | 51, 58.6% | 0.215 |
Systolic pressure, mmHg, median (IQR) | 120 (114–140) | 120 (112–140) | 126 (119–140) | 0.214 |
Diastolic pressure, mmHg, median (IQR) | 80 (70–84) | 80 (70–84) | 80 (70–84) | 0.734 |
Ejection fraction, %, median (IQR) | 62.0 (49.0–68.0) | 62.0 (49.0–68.0) | 60.0 (45.5–68.0) | 0.333 |
TG, mmol/L, median (IQR) | 1.4 (1.1–2.0) | 1.4 (1.1–1.9) | 1.4 (1.0–2.0) | 0.667 |
LDL-C, mmol/L, mean (SD) | 2.2 (0.8) | 2.2 (0.8) | 2.1 (0.8) | 0.245 |
HDL-C, mmol/L, mean (SD) | 0.9 (0.2) | 0.9 (0.2) | 0.9 (0.2) | 0.250 |
ApoA, mmol/L, mean (SD) | 1.1 (0.2) | 1.1 (0.2) | 1.1 (0.2) | 0.754 |
ALT, U/L, median (IQR) | 26.8 (17.3–45.4) | 29.1 (17.8–48.9) | 22.6 (16.4–38.3) | 0.017 |
AST, U/L, median (IQR) | 27.0 (18.9–54.7) | 27.8 (19.6–62.4) | 22.0 (17.4–35.9) | 0.002 |
Blood glucose, mmol/L, median (IQR) | 5.6 (4.9–6.9) | 5.5 (4.9–6.8) | 5.6 (5.0–7.1) | 0.554 |
hsCRP, mg/dL, median (IQR) | 1.4 (0.7–3.2) | 1.3 (0.6–3.2) | 1.4 (0.7–2.9) | 0.935 |
CK, U/L, median (IQR) | 107.7 (66.0–286.9) | 117.1 (69.5–353.1) | 84.0 (57.9–153.9) | 0.002 |
CKMB, U/L, median (IQR) | 15.6 (11.6–32.5) | 15.9 (11.4–38.7) | 14.7 (12.1–24.0) | 0.257 |
pro-BNP, pg/mL, median (IQR) | 267.8 (94.9–831.4) | 264.9 (80.4–827.7) | 289.3 (145.9–813.1) | 0.213 |
Medication at discharge | ||||
Aspirin, n, % | 425, 100% | 338, 100% | 87, 100% | |
Clopidogrel, n, % | 425, 100% | 338, 100% | 87, 100% | |
Statin, n, % | 417, 98.1% | 331, 97.9% | 86, 98.9% | 1.000 |
ACEI/ARB, n, % | 385, 90.6% | 309, 91.4% | 76, 87.4% | 0.247 |
β-blocker, n, % | 374, 88.0% | 298, 88.2% | 76, 87.4% | 0.836 |
ACS type | 0.673 | |||
UA, n, % | 239, 56.4% | 189, 55.9% | 50, 57.5% | |
STEMI, n, % | 126, 29.7% | 103, 30.5% | 23, 26.4% | |
NSTEMI, n, % | 60, 14.1% | 46, 13.6% | 14, 16.1% | |
NYHA classification | 0.163 | |||
I, n, % | 154, 36.2% | 131, 38.8% | 23, 26.4% | |
II, n, % | 242, 56.9% | 186, 55.0% | 56, 64.4% | |
III, n, % | 20, 4.7% | 15, 4.4% | 5, 5.7% | |
IV, n, % | 9, 2.1% | 6, 1.8% | 3, 3.4% |
